BD&L Summit · Munich · 24th & 25th November 2026

BioPharma Deals
BD&L Summit
Munich 2026

Europe's most focused gathering of life sciences dealmakers. Two intensive days of high-calibre deal conversations, curated 1:1 partnering sessions, expert-led panels, and the commercial intelligence that drives licensing, M&A, and strategic partnerships across the global biopharma landscape.

24th & 25th November 2026
Munich, Germany
Senior BD&L Leaders
Event at a Glance
BD&L Summit Munich 2026
Dates: 24th & 25th November 2026
Venue: Science Congress Center, Munich
Audience: Pharma · Biotech · Investors · Service & Solution Providers · Platforms
Focus: Panel discussions · Keynotes · Company Presentations · One to One Meetings
230
Days
14
Hours
32
Mins
00
Secs
Secure Your Seat →
BD&L Leaders
Expert Speakers
2 Intensive Days
1:1 Meetings
30+ Countries
Life sciences conference networking Pharma dealmaking
2026 BD&L
Summit
Event Overview

Europe's BD&L
Epicentre

The BioPharma Deals Conference is the gathering point for the Pharma Biotech dealmakers to initiate, advance, and close deals.

This is not a general pharma congress. It is an exclusive, targeted and BD&L focused summit where every session, every meeting, and every curated interaction is designed with a potential to generate real commercial outcomes, licensing agreements, co-development mandates, investment conversations, and strategic partnerships that reshape pipelines.

  • Exclusive BD&L-only agenda with zero tangential content
  • Pre-vetted, VP-level and above attendee curation
  • 500+ structured 1:1 partnering meetings over two days
Licensing M&A Co-Development Partnering Capital Raising IP Strategy
Register for 2026
Full Programme

Two Days of Pure Deal Focus

Every session, break, and reception is engineered to create deal momentum and meaningful commercial connection.

08:25 – 08:55
Delegate Registration, Welcome Coffee & Badge Collection
Registration
08:55 – 09:00
Chairman's Address
Address
09:00 – 09:20
Panel Discussion 1: The Art of Negotiation in Today’s Market: Creating Win-Win Deals for Pharma and Biotech
  • • Understanding the priorities of both pharma and biotech
  • • Balancing value, risk and long-term partnership goals
  • • Navigating valuation, deal terms and negotiation dynamics
  • • Building trust to achieve successful win-win outcomes
Panel Discussion
09:20 – 09:40
Panel Discussion 2: Early Engagement — When and How to Start the Conversation
  • • Identifying the right trigger points for first contact
  • • Approaching scouts and R&D vs. formal business development channels
  • • Building long-term relationships before the data inflection point
  • • "Soft engagement" strategies: how to stay on the radar without chasing
Panel Discussion
09:45 – 10:30
Company Showcasing 1
Companies present their assets, technologies, and services to potential partners and investors.
Company Pitches
10:30 – 11:15
Mid-Morning Coffee Break: Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
Coffee Break
11:15 – 11:35
Panel Discussion 3: Finding the Right Partner: Aligning Science, Strategy and Commercial Goals
  • • Identifying partners with complementary strengths and shared objectives
  • • Aligning scientific innovation with strategic and commercial priorities
  • • Evaluating long-term fit beyond the asset or technology
  • • Building partnerships that create sustainable value for both sides
Panel Discussion
11:35 – 11:55
Panel Discussion 4: From Opportunity to Outcome: Solving the Execution Challenge
  • • Managing seamless execution from signing to implementation
  • • Overcoming operational and cross-functional challenges
  • • Maintaining alignment between partners throughout the deal lifecycle
  • • Delivering measurable value through effective collaboration
Panel Discussion
12:00 – 13:00
Company Showcasing 2
Companies present their assets, technologies, and services to potential partners and investors.
Company Pitches
13:00 – 14:00
Hosted Networking Lunch — Continued Deal Conversations
Lunch
14:00 – 18:00
Curated 1:1 Partnering & Networking Sessions — Deal Café Open
Pre-scheduled bilateral meetings, informal deal conversations, and facilitated introductions. Meeting rooms and lounge areas available throughout the afternoon.
Networking
16:00 – 16:30
Afternoon Coffee Break: Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
Coffee Break
08:45 – 08:55
Morning Registration & Coffee — Informal Networking
Registration
08:55 – 09:00
Chairman's Address
Address
09:00 – 09:20
Panel Discussion 5: Due Diligence and the VDR — Avoiding Preventable Deal Delays
  • • What the pharma technical teams focus on first (and why)
  • • How to structure a Virtual Data Room that builds confidence quickly
  • • Pre-empting red flags in CMC, IP, and data integrity
  • • Managing the intensity of the diligence process while running the business
Panel Discussion
09:20 – 09:45
Company Showcasing 3
Companies present their assets, technologies, and services to potential partners and investors.
Company Pitches
09:45 – 10:30
Panel Discussion 6: The Future of Pharma Dealmaking: Trends Shaping the Next Generation of Partnerships
  • • Emerging partnership models transforming the dealmaking landscape
  • • The growing role of AI, data and digital innovation in BD&L
  • • Evolving investment priorities and licensing strategies
  • • Preparing for the next generation of pharma and biotech collaborations
Panel Discussion
10:30 – 11:15
Mid-Morning Coffee Break: Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
Coffee Break
11:15 – 11:35
Panel Discussion 7: Regional Deals — Strategic Growth or Value Cap?
  • • When a regional deal (China, Japan, Europe etc.) is the right move for a small biotech
  • • Impact on future global partnering and downstream valuation
  • • Managing governance and rights across multiple territories
  • • Sequencing deals: the pros and cons of "region-first" strategies
Panel Discussion
11:35 – 11:55
Panel Discussion 8: Competition for the Best Assets: How Companies Win the Deal
  • • Why "best science" is no longer enough: the importance of narrative, timing, and positioning
  • • How pharma scouts and BD teams evaluate competing opportunities in real time
  • • Building early credibility before formal partnering discussions begin
  • • The role of speed, internal alignment, and decision-making agility in winning assets
  • • How biotechs differentiate in crowded indication spaces and platform-driven markets
  • • Lessons from competitive deal processes: what consistently wins term sheets today
Panel Discussion
12:00 – 13:00
Company Showcasing 4
Companies present their assets, technologies, and services to potential partners and investors.
Company Pitches
13:00 – 14:00
Hosted Networking Lunch — Continued Deal Conversations
Lunch
14:00 – 18:00
Curated 1:1 Partnering & Networking Sessions — Deal Café Open
Pre-scheduled bilateral meetings, informal deal conversations, and facilitated introductions. Meeting rooms and lounge areas available throughout the afternoon.
Networking
15:30 – 16:00
Afternoon Coffee Break: Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
Coffee Break

Our Speakers

Industry leaders who have shared their deal-making expertise at BioPharma Deals summits. Every speaker holds a real BD&L role and brings current, unfiltered market intelligence.

Dimitri F. Dimitriou
Dimitri F. Dimitriou
Managing Director
DyoDelta Biosciences Ltd.
Caroline Robic
Caroline Robic
R&D Due Diligence Director
Servier
Dr. Ralf Angermund
Dr. Ralf Angermund
Director Search & Evaluation Germany, External Scientific Innovation
Johnson & Johnson Innovative Medicine
Benjamin August
Benjamin August
Senior Director, Search & Evaluation - Research & Technologies
Daiichi Sankyo
Berthold Hinzen, Ph. D.
Berthold Hinzen, Ph. D.
Corporate & Business Development, Global Head of Due Diligence
Novartis
Akiko Tanabe
Akiko Tanabe
Scouting & Transaction Lead, Business Development
Astellas Pharma Europe
Dr. Vinay Pawar
Dr. Vinay Pawar
Scientific Director (Data and AI), R&D External Innovation
Novo Nordisk
Isabelle Scarabin
Isabelle Scarabin
Director, Business Development & Licensing Officer
Bayer
Ricardo Gaminha Pacheco
Ricardo Gaminha Pacheco, MD MBA MPH
Longevity Biotechnology Strategic Partnering, BD&L Senior Director
Insilico Medicine
Christian Kuttruff
Christian Kuttruff
Director, Strategic Partnering, Global Business Development and Licensing
Boehringer Ingelheim
Igor Orshanskiy
Igor Orshanskiy
Head of Business Development
InflaRx
Robert Augustin
Robert Augustin
Director Strategic Partnering Cardiorenalmetabolism, BD&L
Boehringer Ingelheim
Federica Clarissa Pellegrino
Federica Clarissa Pellegrino
Senior Director, Global Legal Business Partnerships, Operations & Innovation
Chiesi Group
Martin Svorc
Martin Svorc
Director, Neurology & Immunology, Business Development & AI Strategy and Enablement Lead
Merck
What's Included

The Full BD&L Experience

01 —
Keynote Addresses

Major keynotes from Chief BD Officers and senior dealmakers at global pharma, covering the topics that define BD&L strategy in 2026 — valuations, therapy areas, deal structure, and market outlook.

02 —
Curated 1:1 Partnering

500+ pre-scheduled bilateral meetings arranged via the conference platform. Each meeting is 20 minutes, pre-screened for mutual relevance, and scheduled to maximise your deal pipeline return from both days.

03 —
Expert Panel Discussions

Curated panel debates featuring Chief BD Officers, General Counsels, investors, and licensing veterans on the toughest deal challenges: term sheet structuring, cross-border complexity, valuation disputes, and post-deal governance.

04 —
Pipeline Pitch Sessions

Structured pipeline presentations where companies present assets directly to an audience of active in-licensors, corporate development leaders, and investors. Followed by facilitated introductions.

05 —
BD&L Masterclasses

Two intensive half-day masterclasses — Due Diligence Excellence and Alliance Management — led by advisors with decades of life sciences transactional experience. Practical frameworks, real case studies, zero theory.

06 —
Evening Reception

Hosted cocktail reception on Day 1 evening, with curated dinner tables by therapy area and deal type. The informal settings where the most candid deal conversations happen and relationships are built for years to come.

Summit Venue

Munich — Europe's
Life Sciences Capital

Munich sits at the heart of Europe's most dynamic life sciences cluster. Home to global pharma operations, a thriving biotech ecosystem, and exceptional international connectivity, it is the natural home for Europe's premier BD&L Summit.

Conference Venue
Science Congress Center Munich (SCCM)
Address
Walther-von-Dyck-Straße 10, 85748 Garching bei München, Germany
Event Dates
24–25 November 2026
Airport
Munich Airport (MUC) — 25 min by taxi · 45 min by U6 subway
Accommodation
Book Your Room
🏷️ Special discounted rate available until 23rd Sep
View on Google Maps
Science Congress Center Munich exterior Modern conference centre interior Garching campus Munich
Summit Partners

Our Partners & Sponsors

BioPharma Deals 2026 is supported by the industry's leading biopharma companies, innovative biotechs, and strategic partners.

What Delegates Say

The BD&L Community Speaks

Who Attends

A Room Full of
Decision-Makers

We apply a rigorous curation process to ensure every attendee holds genuine deal authority. No passengers — every person in the room can initiate and advance a real deal.

01
Chief BD Officers & VP Business Development

Senior BD leaders from Big Pharma, Specialty Pharma, and mid-sized biopharmaceuticals responsible for licensing and partnership strategy at portfolio level.

Licensing · Partnering
02
Biotech CEOs & Founders

Leaders of innovative biotech companies at Series B through commercial stage, actively seeking licensing partners, co-development agreements, and strategic acquirers.

Out-Licensing · Fundraising
03
Life Sciences Investors

Venture capitalists, family offices, and corporate venture arms deploying capital across early and late-stage assets, evaluating in-licensing and co-investment structures.

Venture · Corporate Venture
04
Licensing Directors & Alliance Managers

Deal execution professionals responsible for structuring, negotiating, and closing licensing agreements — from term sheet through contract and ongoing alliance management.

Execution · Alliance Mgmt
05
M&A & Corporate Development Leaders

Corporate development directors and M&A advisors running buy-side and sell-side mandates across pharma, biotech, medtech, and diagnostics.

M&A · Corporate Dev
06
Legal, IP & Financial Advisors

Specialist advisors — transactional lawyers, IP counsel, investment bankers, and financial due diligence experts — who bring deals to fruition and protect value through execution.

Legal · IP · Finance
Practical Information

Everything You Need to Know

Getting There
  • Munich Airport (MUC) — 40 min via S-Bahn S1/S8
  • Frankfurt Airport — 3.5hr by ICE train to Munich Hbf
  • Taxi from Munich Hbf — approx. 10 minutes
  • Conference venue is at Am Tucherpark, Munich
  • Underground: U4/U5 — Odeonsplatz (5 min walk)
Accommodation
  • Hilton Munich Park — venue hotel (preferential rate available)
  • Hotel Mandarin Oriental Munich — 10 min walk
  • Hotel Bayerischer Hof — 15 min walk
  • Hotel code provided post-registration for reduced rates
  • Book early — rooms fill quickly for November dates
On-Site Facilities
  • Exhibition hall with partnering booths available to sponsors
  • Private meeting rooms for 1:1 partnering sessions
  • Business centre with printing and AV facilities
  • Full catering: breakfast, lunch, afternoon breaks, reception
  • Conference app for scheduling and messaging delegates
Delegate Registration

Secure Your Place at Munich 2026

Places are limited and pre-vetted. All registrations are reviewed before confirmation to ensure the quality and seniority of the delegate community.

Delegate Registration

Delegate Packages

1 Delegate
All Access Package
€2,000
Per delegate · All-inclusive

Complete individual conference experience with full access to all sessions and networking opportunities.

3 Delegates · Best Team Value
Strategic Partner Package
€5,000 Save €1,000
For 3 delegates · €1,666.66/person

Enhanced savings for larger teams. Perfect for companies bringing their entire business development team.

Company Showcase

Presentation Packages

1 Delegate · 15-min Stage Slot
Company Showcase I
€5,000
1 delegate + presentation slot

A 15-minute presentation opportunity to introduce your assets, services, platform, and technology to potential partners.

Exhibition

Exhibition Packages

2 Delegates · 10×10 Stand
Standard Exhibition
€5,000
2 delegates + exhibition space

Promote your products, brand, and solutions from a 10×10 exhibition space to industry leaders.

Sponsorship

Brand Sponsorships

1 Delegate · Brand Sponsor
WiFi Sponsorship
€4,000
1 delegate + WiFi branding

Your logo prominently displayed on WiFi access materials throughout the venue.

1 Delegate · Constant Visibility
Lanyard Sponsorship
€4,000
1 delegate + lanyard branding

Your logo on every attendee's lanyard for continuous two-day visibility.

1 Delegate · High Visibility
Name Badge Sponsorship
€5,000
1 delegate + badge branding

Your logo on every attendee's name badge. Ensures your brand is seen throughout every handshake.

1 Delegate · Sustainability
Water Refill Station
€5,000
1 delegate + water station branding

Sponsor the water stations and associate your brand with sustainability.

1 Delegate · Premium Sponsor
Luncheon Sponsorship
€10,000
1 delegate + luncheon branding

Premium sponsorship with your brand associated with the main lunch event. Maximum visibility.




Mastering Deal Making in Pharma & Biotech

BD&L Training Course

An intensive 2-day training course led by industry experts with 35+ years of deal-making experience. Choose the access level that best fits your networking and learning goals.

Training Only
Standard Access
€1,250
Per delegate · Training only

Perfect for professionals focused purely on upskilling. Includes 2-day access to all core training modules, course materials, and certification.

Munich · 24–25 November 2026

Your Next Deal
Starts Here

Join Europe's most focused gathering of BD&L professionals. Two days. One shared ambition: to close the deals that advance the science of life.